Madhusudhana KC, Newsom RS. Central retinal vein occlusion: the therapeutic options. Can J Ophthalmol. 2007 Apr. 42(2):193-5. [QxMD MEDLINE Link].
Newman-Casey PA, Stem M, Talwar N, Musch DC, Besirli CG, Stein JD. Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan. Ophthalmology. Oct. 121:1939-48.
Bowers DK, Finkelstein D, Wolff SM, Green WR. Branch retinal vein occlusion. A clinicopathologic case report. Retina. 1987. 7(4):252-9. [QxMD MEDLINE Link].
Zhao J, Sastry SM, Sperduto RD, Chew EY, Remaley NA. Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology. 1993 Mar. 100(3):423-8. [QxMD MEDLINE Link].
Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981. 1(1):27-55. [QxMD MEDLINE Link].
Ho JD, Tsai CY, Liou SW, et al. Seasonal variations in the occurrence of retinal vein occlusion: a five-year nationwide population-based study from Taiwan. Am J Ophthalmol. 2008 Apr. 145(4):722-728. [QxMD MEDLINE Link].
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol. 1997 Apr. 115(4):486-91. [QxMD MEDLINE Link].
Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology. 2011 Jan. 118(1):119-133.e1-2. [QxMD MEDLINE Link]. [Full Text].
Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010 Feb. 117(2):313-9.e1. [QxMD MEDLINE Link].
Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000. 98:133-41; discussion 141-3. [QxMD MEDLINE Link]. [Full Text].
Jonas JB, Harder B. Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusion. Am J Ophthalmol. 2007 Jan. 143(1):112-6. [QxMD MEDLINE Link].
Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007 Mar. 114(3):507-19, 524. [QxMD MEDLINE Link].
Weis E, Gan KD, Hinz BJ, et al. A retrospective cohort study of radial optic neurotomy for severe central retinal vein occlusions. Can J Ophthalmol. 2008 Feb. 43(1):73-8. [QxMD MEDLINE Link].
D'Amico DJ, Lit ES, Viola F. Lamina puncture for central retinal vein occlusion: results of a pilot trial. Arch Ophthalmol. 2006 Jul. 124(7):972-7. [QxMD MEDLINE Link].
Ascaso FJ, Padgett E, Núñez E, Villén L, Grzybowski A, Cristóbal JA. Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case-control study. Graefes Arch Clin Exp Ophthalmol. 2014 Mar. 252(3):375-81. [QxMD MEDLINE Link].
Raja MS, Goldsmith C. Interventions for CRVO. Ophthalmology. 2008 Jan. 115(1):219; author reply 219-20. [QxMD MEDLINE Link].
Vitreous-Retina-Macula Consultants of New York. Retinal Venous occlusive Disease: Branch Retinal Occlusion/Central Retinal Occlusion. Available at http://www.vrmny.com. Accessed: April 2008.
Kinge B, Stordahl PB, Forsaa V, Fossen K, Haugstad M, Helgesen OH, et al. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study. Am J Ophthalmol. 2010 Sep. 150(3):310-4. [QxMD MEDLINE Link].
Yamamoto T, Kamei M, Sayanagi K, Matsumura N, Nishida K, Sakaguchi H. Simultaneous intravitreal injection of triamcinolone acetonide and tissue plasminogen activator for central retinal vein occlusion: a pilot study. Br J Ophthalmol. 2011 Jan. 95(1):69-73. [QxMD MEDLINE Link].
Farahvash MS, Moghaddam MM, Moghimi S, et al. Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid. Can J Ophthalmol. 2008 Feb. 43(1):79-83. [QxMD MEDLINE Link].
Wright JK, Franklin B, Zant E. Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen. Undersea Hyperb Med. 2007 Sep-Oct. 34(5):315-9. [QxMD MEDLINE Link].
Ozdek S, Deren YT, Gurelik G, et al. Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion. Ophthalmic Res. 2008. 40(1):26-31. [QxMD MEDLINE Link].
Kawaji T, Takano A, Inomata Y, et al. Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion. Br J Ophthalmol. 2008 Jan. 92(1):81-3. [QxMD MEDLINE Link].
Papadia M, Misteli M, Jeannin B, Herbort CP. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications. Int Ophthalmol. 2014 Sep 23. [QxMD MEDLINE Link].
Sarao V, Bertoli F, Veritti D, Lanzetta P. Pharmacotherapy for treatment of retinal vein occlusion. Expert Opin Pharmacother. 2014 Sep 5. 1-12. [QxMD MEDLINE Link].
Batioglu F, Astam N, Ozmert E. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol. 2008 Feb. 28(1):59-61. [QxMD MEDLINE Link].
Binder S, Aggermann T, Brunner S. Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series. Graefes Arch Clin Exp Ophthalmol. 2007 Oct. 245(10):1447-52. [QxMD MEDLINE Link].
Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol. 2007 Dec. 144(6):864-71. [QxMD MEDLINE Link].
Gandhi JS. Natural history of non-ischemic central retinal vein occlusion versus iatrogenic intervention. J Postgrad Med. 2007 Oct-Dec. 53(4):270; author reply 270-1. [QxMD MEDLINE Link].
Gumus K, Kadayifcilar S, Eldem B, et al. Assessment of the role of thrombin activatable fibrinolysis inhibitor in retinal vein occlusion. Retina. 2007 Jun. 27(5):578-83. [QxMD MEDLINE Link].
Hasselbach HC, Ruefer F, Feltgen N, et al. Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases. Graefes Arch Clin Exp Ophthalmol. 2007 Aug. 245(8):1145-56. [QxMD MEDLINE Link].
Keith S, Humphries R. Current Diagnosis & Treatment of Emergency Medicine. 6th ed. McGraw-Hill Co; 2008.
Koizumi H, Ferrara DC, Brue C, et al. Central retinal vein occlusion case-control study. Am J Ophthalmol. 2007 Dec. 144(6):858-863. [QxMD MEDLINE Link].
Kreutzer TC, Alge CS, Wolf AH, et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol. 2008 Mar. 92(3):351-5. [QxMD MEDLINE Link].
Leoncini G, Bruzzese D, Signorello MG, et al. Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost. 2007 Feb. 97(2):218-27. [QxMD MEDLINE Link].
Mohamed Q, McIntosh RL, Saw SM, et al. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007 Mar. 114(3):507-19, 524. [QxMD MEDLINE Link].
Morley M, Heier J. Ophthalmology. Part 8; Section 5. 2nd ed. Mosby; 2004.
Recchia FM, Chen E, Li C, et al. Use of cox-2 inhibitors in patients with retinal venous occlusive disease. Retina. 2008 Jan. 28(1):134-7. [QxMD MEDLINE Link].
Sodi A, Giambene B, Marcucci R, et al. Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion. Eur J Ophthalmol. 2008 Mar-Apr. 18(2):233-8. [QxMD MEDLINE Link].
Napal JJ, Neila S, Pérez-Montes R, Sierra I, Ruiz S, Hernández JL. The role of coagulation disorders in patients with retinal vein occlusion. QJM. 2016 Feb. 109 (2):97-102. [QxMD MEDLINE Link].
Rehak M, Rehak J, Müller M, Faude S, Faude F, Siegemund A, et al. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis. Thromb Haemost. 2008 May. 99 (5):925-9. [QxMD MEDLINE Link].
Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005 Jun. 93 (6):1021-6. [QxMD MEDLINE Link].